We are live on
!
Find out more
PCML
Pavaki Capital Management LLC Portfolio holdings
AUM
$287M
This Fund
S&P 500
This Quarter
Est. Return
+0.76%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$235M
AUM Growth
-$19.8M
(-7.8%)
Cap. Flow
+$13.6M
Cap. Flow
% of AUM
5.79%
Top 10 Holdings %
Top 10 Hldgs %
50.47%
Holding
162
New
31
Increased
16
Reduced
7
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$13.2M |
| 2 |
iShares MSCI Singapore ETF
EWS
|
+$1.69M |
| 3 |
ESPR
Esperion Therapeutics
ESPR
|
+$1.3M |
| 4 |
B
Barrick Mining
B
|
+$1.27M |
| 5 |
NewAmsterdam Pharma
NAMS
|
+$1.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$8.8M |
| 2 |
ARS Pharmaceuticals
SPRY
|
+$5.71M |
| 3 |
Organon & Co
OGN
|
+$3.01M |
| 4 |
Roivant Sciences
ROIV
|
+$868K |
| 5 |
Altimmune
ALT
|
+$778K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.32% |
| 2 | Materials | 13.21% |
| 3 | Energy | 8.84% |
| 4 | Technology | 4.85% |
| 5 | Communication Services | 4.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
CALL
McDonald's
MCD
$195B
| $870K | 0.37% |
2,800
| – | – |
|
52
SLB Ltd
SLB
$75B
| $822K | 0.35% |
+16,000
| New | +$777K |
|
53
Advanced Micro Devices
AMD
$789B
| $814K | 0.35% |
4,000
| – | – |
|
54
UBS Group
UBS
$176B
| $730K | 0.31% |
+19,000
| New | +$813K |
|
55
PUT
Invesco NASDAQ 100 ETF
QQQM
$102B
| $713K | 0.3% |
3,000
| – | – |
|
56
Itaú Unibanco
ITUB
$87.5B
| $691K | 0.29% |
82,400
| – | – |
|
57
Ardelyx
ARDX
$988M
| $689K | 0.29% |
115,000
| – | – |
|
58
CALL
SAP
SAP
$238B
| $685K | 0.29% |
4,000
| – | – |
|
59
BlackRock Income Trust
BKT
$341M
| $674K | 0.29% |
63,810
| – | – |
|
60
OraSure Technologies
OSUR
$279M
| $657K | 0.28% |
219,033
| – | – |
|
61
PUT
State Street SPDR S&P Semiconductor ETF
XSD
$3.04B
| $652K | 0.28% |
2,000
| – | – |
|
62
Kaspi.kz JSC
KSPI
$17.2B
| $644K | 0.27% |
8,700
+4,000
| +85% | +$302K |
|
63
Biogen
BIIB
$30.7B
| $642K | 0.27% |
3,500
| – | – |
|
64
Halliburton
HAL
$26.6B
| $624K | 0.27% |
16,000
+10,000
| +167% | +$346K |
|
65
Kodiak Gas Services
KGS
$6.05B
| $612K | 0.26% |
+10,500
| New | +$510K |
|
66
Merck
MRK
$318B
| $601K | 0.26% |
5,000
| – | – |
|
|
PDS
67
Precision Drilling
PDS
$974M
| $590K | 0.25% |
+6,000
| New | +$514K |
|
|
DHC
68
Diversified Healthcare Trust
DHC
$2.14B
| $564K | 0.24% |
85,000
| – | – |
|
69
Nokia
NOK
$52.3B
| $563K | 0.24% |
70,000
| – | – |
|
|
ARIS
70
Aris Mining
ARIS
$3.59B
| $557K | 0.24% |
30,000
| – | – |
|
71
Icon
ICLR
$12.7B
| $553K | 0.24% |
5,000
+3,200
| +178% | +$437K |
|
72
The RMR Group
RMR
$332M
| $549K | 0.23% |
35,500
| – | – |
|
73
Pan American Silver
PAAS
$21.6B
| $546K | 0.23% |
+10,000
| New | +$577K |
|
74
Lantheus
LNTH
$6.59B
| $539K | 0.23% |
7,100
| – | – |
|
|
SVM
75
Silvercorp Metals
SVM
$2.53B
| $537K | 0.23% |
50,000
| – | – |
|
Similar funds
GCM
AWM
EA
MAG
PAM
MM
FCG
A
Pavaki Capital Management LLC's Q1 2026 Portfolio in Review
As of Q1 2026, Pavaki Capital Management LLC held 162 positions worth $235M, down 7.8% from $255M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Pavaki Capital Management LLC deployed $13.6M of net new capital in Q1 2026, opening 31 new positions and adding to 16 existing holdings. Its largest new stake was iShares MSCI Singapore ETF: 60,000 shares worth $1.69M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 30% a quarter earlier, followed by Materials and Energy.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $8.8M trimmed.
- Pavaki Capital Management LLC's largest Q1 2026 buy was iShares MSCI Singapore ETF: 60,000 shares worth $1.69M.
- Pavaki Capital Management LLC added most to Chevron in Q1 2026, an estimated $13.2M increase.
- Pavaki Capital Management LLC's biggest Q1 2026 reduction was Regeneron Pharmaceuticals, cutting an estimated $8.8M.
- Pavaki Capital Management LLC fully exited Roivant Sciences in Q1 2026, selling an estimated $868K.
- Pavaki Capital Management LLC's ten largest holdings make up 50% of its $235M portfolio in Q1 2026.
- Pavaki Capital Management LLC opened 31 new positions and closed 6 in Q1 2026.
- Pavaki Capital Management LLC's portfolio value fell 7.8% quarter-over-quarter to $235M.
Based on Pavaki Capital Management LLC's 13F filing for Q1 2026, filed 7 Aug 2026.